Cargando…

Low-Dose Dextromethorphan for the Treatment of Fibromyalgia Pain: Results from a Longitudinal, Single-Blind, Placebo-Controlled Pilot Trial

OBJECTIVE: Fibromyalgia (FM) is a debilitating chronic pain condition with few treatment options. Central sensitization and neuroinflammation have been forwarded as models of FM pathophysiology, both of which indicate dextromethorphan (DXM) as a potential treatment. DXM is an NMDA-receptor antagonis...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Christina, Ness, Timothy J, Younger, Jarred W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851375/
https://www.ncbi.nlm.nih.gov/pubmed/33542651
http://dx.doi.org/10.2147/JPR.S285609

Ejemplares similares